A worldwide leader in biologics manufacturing, Amgen has an outstanding track record of reliably delivering high-quality medicines to patients who need them.1,2
Amgen is committed to ensuring doctors and patients can rely on the quality and availability of our treatments, including our biosimilars. We have an extensive global manufacturing network, including eight manufacturing plants around the globe, which we have developed as part of a multifaceted approach to help prevent drug shortages and to help ensure a reliable supply to every patient, every time.
This approach employs risk management tactics that involve a continuous process of identifying, preventing, and responding to risks holistically.
Amgen implements product security programs to help ensure
reliable supply of its medicines to patients.